FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely oxycodone hydrochloride 7.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 750 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely loperamide hydrochloride 2 milligram and simeticone 125 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely felodipine 2.5 milligram and ramipril 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine hydrochloride 11 milligram and theophylline 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely methyclothiazide 2.5 milligram and reserpine 100 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely felodipine 5 milligram and ramipril 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 50 milligram and methyldopa 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 50 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 2 milligram and norethisterone acetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mestranol 50 microgram and norethisterone 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 400 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lovastatin 40 milligram and nicotinic acid 1 gram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 20 microgram and gestodene 75 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and quinapril 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norgestimate 180 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and reserpine 125 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diphenhydramine 25 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 50 microgram and norethisterone 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 2.5 milligram and ibuprofen 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 50 milligram and reserpine 125 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ibuprofen 200 milligram and pseudoephedrine 30 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 500 microgram and norethisterone acetate 100 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diltiazem maleate 219 milligram and enalapril maleate 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and norgestrel 300 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 750 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and triamterene 37.5 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely methionine 100 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 50 microgram and norgestrel 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and triamterene 37.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 7.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ferrous fumarate 324 milligram and folic acid 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 650 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier

    Start Previous Page 4 of 35 Next End

    This concept is not in any reference sets

    Back to Start